# A Study to Compare the Amount of Two Forms of Tafamidis in the Blood of Healthy Adults Under Fed Conditions

> **NCT07470866** · PHASE1 · RECRUITING · sponsor: **Pfizer** · enrollment: 24 (estimated)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** Tafamidis (Reference)
- **DRUG:** Tafamidis (Test)

## Key facts

- **NCT ID:** NCT07470866
- **Lead sponsor:** Pfizer
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2026-03-23
- **Primary completion:** 2026-06-02
- **Final completion:** 2026-06-02
- **Target enrollment:** 24 (ESTIMATED)
- **Last updated:** 2026-04-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07470866

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07470866, "A Study to Compare the Amount of Two Forms of Tafamidis in the Blood of Healthy Adults Under Fed Conditions". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT07470866. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*